PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

Subjects:

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Representative images showed calcium deposition (red). …”

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Changes in TEER with increasing culture time on days 1–22. …”

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P_i‐induced VSMCs. …”

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

PRISMA flow chart of the screening process. by Mohamed R. Abdelraouf (21501468)

“…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”

Screening Sheet: A sheet that contains the full screening process that we used to include or exclude any study. by Mohamed R. Abdelraouf (21501468)

Raw and processed data files. by Swati M. Surkar (8399427)

“…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. Additionally, DT training led to decreased activation in the bilateral PFC and vestibular cortices, specifically for complex DT condition, suggesting enhanced attentional resource allocation and optimized vestibular input processing, indicative of neural efficiency. …”

Uncropped blots corresponding to Fig 3A, provided for assessment of band specificity and loading consistency. by Tetsuya Kakita (4922584)

Trust change by gender. by Alain Abi-Rizk (8549358)

Subjects:

Trust change by age group. by Alain Abi-Rizk (8549358)

Subjects:

Trust change by education level. by Alain Abi-Rizk (8549358)

Subjects:

Trust change by source of science information. by Alain Abi-Rizk (8549358)

Subjects:

Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

Subjects:

Distribution of individual change in trust in science before and after the pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

Subjects: